基本資料

投資策略

此基金主要透過投資於環球的大至中型健康護理行業公司，以提供較高回報。

基金經理人

• Wilkin Scott
• 資歷 8年(2016-08-31 至今)

• Scott is the Head of the Global Intrinsic Value Equity
  team and co-PM for our Global equity portfolios. He is
  also Director of Research (DOR); responsible for
  managing the 13-member analyst team and driving
  research quality standards across the Global Intrinsic
  Value platform.
  In 2012, Scott was promoted to the position of DOR for
  the US Intrinsic Value equity team. In this role, Scott
  managed a team of six sector-based analysts and lead
  company and industry-level research. Scott was also the
  lead portfolio manager of the Intrinsic Value equity
  team's Global Healthcare and UBS Healthcare
  Long/Short strategies.
  Prior to being named DOR and portfolio manager, Scott
  was a Senior Investment Analyst and Sector Head for the
  health care analyst team. His responsibilities included
  fundamental company and industry-level research.

• Konosky Matthew
• 資歷 8年(2016-08-31 至今)

• Matthew Konosky is the Lead Healthcare Portfolio
  Manager and a Senior Investment Analyst on UBS Asset
  Management's US Intrinsic Value Equity Team. In his
  portfolio manager role, Matthew is Lead Portfolio
  Manager for the Global Healthcare Lux Fund as well as
  Deputy Portfolio Manager for the Global Biotech Lux
  Fund.
  Analyst responsibilities include fundamental company
  and industry-level research and development of
  company earnings models for the global
  pharmaceuticals and health care services sectors.
  Prior to joining the firm in 2006, Matthew worked as
  health care services analyst at Sanford C. Bernstein in
  New York and as a senior consultant at Mars & Co.
  serving several Fortune 500 health care clients.
  Matthew has also served as a member of the MIT
  Educational Counsel since 1997.

基金費用

聯絡資訊